The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Cardiac Complications Attributed to Chloroquine and Hydroxychloroquine: A Systematic Review of the Literature
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A method for estimating the probability of adverse drug reactions
Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., Janecek, E., Domecq, C., & Greenblatt, D. J. (1981) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1981.154 · Cited by 11,914
Singh, J. A., Furst, D. E., Bharat, A., Curtis, J. R., Kavanaugh, A. F., Kremer, J. M., Moreland, L. W., O'Dell, J., Winthrop, K. L., Beukelman, T., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21641 · Cited by 1,789
Hahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21664 · Cited by 1,463
The Medical Dictionary for Regulatory Activities (MedDRA)
Brown, E. G., Wood, L., & Wood, S. (1999) · Drug Safety · doi:10.2165/00002018-199920020-00002 · Cited by 1,390
Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)
Marmor, M. F., Kellner, U., Lai, T. Y. Y., Melles, R. B., & Mieler, W. F. (2016) · Ophthalmology · doi:10.1016/j.ophtha.2016.01.058 · Cited by 1,164
Fabry disease defined: baseline clinical manifestations of 366 patients in the Fabry Outcome Survey
Mehta, A., Ricci, R., Widmer, U., Dehout, F., Garcia de Lorenzo, A., Kampmann, C., Linhart, A., Sunder‐Plassmann, G., Ries, M., & Beck, M. (2004) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2004.01309.x · Cited by 848
Bertsias, G., Ioannidis, J. P. A., Boletis, J., Bombardieri, S., Cervera, R., Dostal, C., Font, J., Gilboe, I. M., Houssiau, F., Huizinga, T., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.070367 · Cited by 762
Sado, D. M., White, S. K., Piechnik, S. K., Banypersad, S. M., Treibel, T., Captur, G., Fontana, M., Maestrini, V., Flett, A. S., Robson, M. D., et al. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.112.000070 · Cited by 541
Lysosomes, pH and the Anti-malarial Action of Chloroquine
HOMEWOOD, C. A., WARHURST, D. C., PETERS, W., & BAGGALEY, V. C. (1972) · Nature · doi:10.1038/235050a0 · Cited by 530
Prognostic Value of Late Gadolinium Enhancement in Clinical Outcomes for Hypertrophic Cardiomyopathy
Green, J. J., Berger, J. S., Kramer, C. M., & Salerno, M. (2012) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2011.11.021 · Cited by 452
Cardiotoxicity of antimalarial drugs
White, N. J. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70187-1 · Cited by 349
Mehta, A., Beck, M., Elliott, P., Giugliani, R., Linhart, A., Sunder-Plassmann, G., Schiffmann, R., Barbey, F., Ries, M., & Clarke, J. (2009) · The Lancet · doi:10.1016/s0140-6736(09)61493-8 · Cited by 273
Chronic Hydroxychloroquine Use Associated with QT Prolongation and Refractory Ventricular Arrhythmia
Chen, C.-Y., Wang, F.-L., & Lin, C.-C. (2006) · Clinical Toxicology · doi:10.1080/15563650500514558 · Cited by 270
Thompson, R. B., Chow, K., Khan, A., Chan, A., Shanks, M., Paterson, I., & Oudit, G. Y. (2013) · Circulation: Cardiovascular Imaging · doi:10.1161/circimaging.113.000482 · Cited by 194
Hydroxychloroquine-Induced Cardiomyopathy: Case Report, Pathophysiology, Diagnosis, and Treatment
Yogasundaram, H., Putko, B. N., Tien, J., Paterson, D. I., C̆ujec, B., Ringrose, J., & Oudit, G. Y. (2014) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2014.08.016 · Cited by 166
Sharma, T. S., Wasko, M. C. M., Tang, X., Vedamurthy, D., Yan, X., Cote, J., & Bili, A. (2016) · Journal of the American Heart Association · doi:10.1161/jaha.115.002867 · Cited by 161
Costedoat-Chalumeau, N., Hulot, J., Amoura, Z., Leroux, G., Lechat, P. P., Funck‐Brentano, C., & Pietté, J. C. (2007) · Rheumatology · doi:10.1093/rheumatology/kel402 · Cited by 159
Chloroquine: Modes of action of an undervalued drug
Thomé, R., Lopes, S. C. P., Costa, F. T. M., & Verinaud, L. M. C. (2013) · Immunology Letters · doi:10.1016/j.imlet.2013.07.004 · Cited by 152
Cytochrome P450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes
Kim, K., Park, J. Y., Lee, J., & Lim, S. (2003) · Archives of Pharmacal Research · doi:10.1007/bf02976712 · Cited by 152
Nord, J. E., Shah, P. K., Rinaldi, R. Z., & Weisman, M. H. (2004) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2003.09.012 · Cited by 137
Diagnosis of Chloroquine Cardiomyopathy by Endomyocardial Biopsy
Ratliff, N. B., Estes, M. L., Myles, J. L., Shirey, E. K., & McMahon, J. T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198701223160405 · Cited by 121
Fasano, S., Pierro, L., Pantano, I., Iudici, M., & Valentini, G. (2017) · The Journal of Rheumatology · doi:10.3899/jrheum.161351 · Cited by 118
Chloroquine causes lysosomal dysfunction in neural retina and RPE: implications for retinopathy
Mahon, G. J., Anderson, H. R., Gardiner, T. A., McFarlane, S., Archer, D. B., & Stitt, A. W. (2004) · Current Eye Research · doi:10.1076/ceyr.28.4.277.27835 · Cited by 108
Clinical Pharmacokinetics of Slow-Acting Antirheumatic Drugs
Tett, S. E. (1993) · Clinical Pharmacokinetics · doi:10.2165/00003088-199325050-00005 · Cited by 95
O’Laughlin, J. P., Mehta, P. H., & Wong, B. C. (2016) · Case Reports in Cardiology · doi:10.1155/2016/4626279 · Cited by 92
Rewcastle, N. B. (1965) · Archives of Neurology · doi:10.1001/archneur.1965.00460300018003 · Cited by 88
Morgan, N. D., Patel, S. V., & Dvorkina, O. (2013) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31829d5e50 · Cited by 80
Whisnant, J. P., Espinosa, R. E., Kierland, R. R., & Lambert, E. H. (1963) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)10288-7 · Cited by 80
Roos, J. M., Aubry, M.-C., & Edwards, W. D. (2002) · Cardiovascular Pathology · doi:10.1016/s1054-8807(02)00118-7 · Cited by 76
Prevalence of intraventricular block in the general population: The Framingham Study
Kreger, B. E., Anderson, K. M., & Kannel, W. B. (1989) · American Heart Journal · doi:10.1016/0002-8703(89)90630-3 · Cited by 70
Cardiac toxicity secondary to long term treatment with chloroquine
Cervera, Á., ESPINOSA, G., CERVERA, R., FONT, J., & INGELMO, M. (2001) · Annals of the Rheumatic Diseases · doi:10.1136/ard.60.3.301 · Cited by 65
High incidence of autoantibodies in Fabry disease patients
Martínez, P., Aggio, M. C., & Rozenfeld, P. A. (2007) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-007-0513-2 · Cited by 62
Metabolism of chloroquine and hydroxychloroquine in albino and pigmented rats
McChesney, E. W., Banks, W. F., & Sullivan, D. (1965) · Toxicology and Applied Pharmacology · doi:10.1016/0041-008x(65)90050-5 · Cited by 60
Inhibition of cardiomyocyte lysosomal activity in hydroxychloroquine cardiomyopathy
Frustaci, A., Morgante, E., Antuzzi, D., Russo, M. A., & Chimenti, C. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.03.112 · Cited by 59
Keating, R. J., Bhatia, S., Amin, S., Williams, A. W., Sinak, L. J., & Edwards, W. D. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2005.01.012 · Cited by 52
Chloroquine-induced cardiomyopathy.
McAllister, H. A., Vj, F., Rj, H., Ne, S., & Bossart, M. I. (1987) · PubMed · Cited by 52
Chloroquine-induced cardiomyopathy-echocardiographic features
Naqvi, T. Z., Luthringer, D., Marchevsky, A. M., Saouf, R., Gul, K. M., & Buchbinder, N. A. (2005) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2004.09.029 · Cited by 48
Case 11-2011: A 47-Year-Old Man with Systemic Lupus Erythematosus and Heart Failure
Newton‐Cheh, C., Lin, A. E., Baggish, A. L., & Wang, H. (2011) · New England Journal of Medicine · doi:10.1056/nejmcpc1011319 · Cited by 37
Fatal Antimalarial-Induced Cardiomyopathy: Report of 2 Cases
Azimian, M., Gultekin, S. H., Hata, J. L., Atkinson, J. B., Ely, K., Fuchs, H. A., & Mobley, B. C. (2012) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0b013e31826852db · Cited by 30
Cardiovascular disease in rheumatoid arthritis: medications and risk factors in China
Li, C., Wang, X., Ji, H., Zhang, X. Y., Li, X. F., Wang, L. Z., Wang, C., Wang, Y.-F., Yang, R., Wang, G. C., et al. (2017) · Clinical Rheumatology · doi:10.1007/s10067-017-3596-7 · Cited by 24
Cardiotoxicity after low-dose chloroquine antimalarial therapy
Fragasso, G., Sanvito, F., Baratto, F., et al. (2009) · Heart and Vessels · doi:10.1007/s00380-008-1144-8 · Cited by 23
Hydroxychloroquine-Induced Cardiomyopathy in Systemic Lupus Erythematosus
Tselios, K., Gladman, D. D., Harvey, P., Mak, S. S., Chantal, M., BUTANY, J. W., & Urowitz, M. B. (2016) · JCR Journal of Clinical Rheumatology · doi:10.1097/rhu.0000000000000400 · Cited by 23
Cabot, R. C., Scully, R. E., Mark, E. J., McNeely, W. F., McNeely, B. U., Upchurch, K. S., & Medeiros, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809223191207 · Cited by 17
Chloroquine and cardiac arrhythmia: case report.
Siqueira‐Batista, R., Ramos, A. N., Pessanha, B. S. S., Sforza-de-Almeida, M. P., & Potsch, D. F. (1998) · PubMed · Cited by 16
Heart failure in a woman with SLE, anti-phospholipid syndrome and Fabry’s disease
Nandagudi, A. C., Jury, E. C., Alonzi, D. S., Butters, T. D., Hughes, S., & Isenberg, D. A. (2013) · Lupus · doi:10.1177/0961203313497116 · Cited by 15
Sabato, L. A., Mendes, L. A., & Cox, Z. L. (2016) · Journal of Pharmacy Practice · doi:10.1177/0897190016655726 · Cited by 12
Severe sepsis: take care, take part
Huggan, P. J. (2011) · Internal Medicine Journal · doi:10.1111/j.1445-5994.2010.02383.x · Cited by 8
Cited by
Mechanisms of action of hydroxychloroquine and chloroquine:implications for rheumatology
Schrezenmeier, E., & Dörner, T. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0372-x · Cited by 1,468
Guzik, T. J., Mohiddin, S. A., Dimarco, A., Patel, V., Savvatis, K., Marelli-Berg, F. M., Madhur, M. S., Tomaszewski, M., Maffia, P., D’Acquisto, F., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa106 · Cited by 1,440
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Sevestre, J., Mailhe, M., Doudier, B., Aubry, C., Amrane, S., et al. (2020) · Travel Medicine and Infectious Disease · doi:10.1016/j.tmaid.2020.101663 · Cited by 765
COVID-19: Immunology and treatment options
Felsenstein, S., Herbert, J. A., McNamara, P. S., & Hedrich, C. M. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108448 · Cited by 669
Lane, J. C. E., Weaver, J., Kostka, K., Duarte-Salles, T., Abrahao, M. T. F., Alghoul, H., Alser, O., Alshammari, T. M., Biedermann, P., Banda, J. M., et al. (2020) · The Lancet Rheumatology · doi:10.1016/s2665-9913(20)30276-9 · Cited by 258
“…large-scale evidence was found that investigated the real-world safety of hydroxychloroquine compared with other first-line disease-modifying antirheumatic drugs, especially in combination with macrolide antibiotics such as azithromycin, which have been proposed for use as a treatment for COVID-19.”
Metadata
- Authors
- Chatre, C., Roubille, F., Vernhet, H., Jorgensen, C., & Pers, Y.-M.
- Venue
- Drug Safety
- Published
- 2018-06-01
- Volume
- 41
- Issue
- 10
- Pages
- 919-931
- ISSN
- 0114-5916 (ISSN-L)
- 1179-1942
- OpenAlex
- W2806330066
- Cited by
- 397
- References
- 47
- FWCI
- 15.03
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.